Research news
Triple Negative Trial reveals chemotherapy drug as a long awaited 'targeted therapy' for patients
Women with triple negative breast cancer lack the targeted treatments that are available for other types of breast cancer
How Breast Cancer Now helped discover PARP inhibitors
For over 25 years, researchers at the Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research, London, have been d...